James K. Fong SEC EDGAR Filings (CIK 0001916577)

SEC EDGAR filings, ownership reports, and insider transactions for James K. Fong.

Business address
C/O Cti Biopharma Corp, 3101 Western Avenue, Suite 800, Seattle, WA, 98121
Get insider transactions for this reporting owner
James K. Fong has filed 4 SEC EDGAR filings since 11 Mar 2022

Latest Filings

Recent SEC filings for James K. Fong including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jun 2023 26 Jun 2023 000-28386
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 16 Mar 2023 14 Mar 2023 000-28386
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 26 Jan 2023 24 Jan 2023 000-28386
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 11 Mar 2022 28 Feb 2022 000-28386

About this filer

James K. Fong files with the SEC under CIK 0001916577. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages